Pirjo M. Laakkonen
Helsinki, 00014, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Intracranial Human BT12 Glioblastoma Xenograft is [18F]FET PET Negative but 6-[18F]Fluoronicotinic Acid PET Positive: Exploring a Novel Approach for Clinical Glioblastoma Imaging.
Journal: Molecular pharmaceutics
Published: June 09, 2026
Differential cytotoxic effect of polybrene on distinct glioblastoma subtypes.
Journal: Neuroscience
Published: January 28, 2026
Differential cytotoxic effect of polybrene on distinct glioblastoma subtypes.
Journal: Neuroscience
Published: January 28, 2026
Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.
Journal: Acta neuropathologica communications
Published: December 04, 2025
Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models.
Journal: Cancer cell international
Published: July 04, 2025
Utilizing Monocarboxylate Transporter 1-Mediated Blood-Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[18F]Fluoronicotinic Acid.
Journal: Molecular pharmaceutics
Published: July 03, 2025
Therapeutic Reprogramming of Glioblastoma Phenotypic States Using Multifunctional Heparin Nanoparticles.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 28, 2025
Rapid cleavage of 6-[18F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules.
Journal: EJNMMI radiopharmacy and chemistry
Published: May 09, 2025
Deciphering the Dialogue between Brain Tumors, Neurons, and Astrocytes.
Journal: The American journal of pathology
Published: December 13, 2024
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Journal: Translational oncology
Published: September 20, 2024
Switching the Chemoselectivity in the Preparation of [18F]FNA-N-CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3.
Journal: Molecular pharmaceutics
Published: July 15, 2024
Last Updated: 09/26/2026